\-\ Texto\\:\\ \ \(0\)\
\-\ due\\ to\\ an\\ interval\\ increase\\ in\\ size\\ of\\ the\\ mass\\ from\\ 4\\.5\\ x\\ 4\\.1\\ cm\\ to\\ 5\\.3\\ x\\ 4\\.2\\ cm\\,\\ and\\ the\\ increased\\ risk\\ of\\ hemorrage\\,\\ treatment\\ was\\ indicated\\.\\ \\ the\\ patient\\ underwent\\ selective\\ catheter\\ based\\ embolization\\,\\ as\\ embolization\\ is\\ an\\ effective\\,\\ minimally\\ invasive\\ treatment\\.\\ \\ the\\ technical\\ success\\ rate\\ is\\ near\\ 100\\%\\,\\ with\\ a\\ rare\\ incidence\\ of\\ recurrence\\ in\\ sporadic\\ amls\\.\ \(0\)\
\-\ kothary\\ n\\,\\ soulen\\ mc\\,\\ clark\\ tw\\,\\ et\\ al\\.\\ renal\\ angiomyolipoma\\:\\ long\\-term\\ results\\ after\\ arterial\\ embolization\\.\\ j\\ vasc\\ interv\\ radiol\\.\\ 2005\\;\\ 16\\:45\\-50\\.\ \(0\)\
\-\ contrast\\ enhanced\\ axial\\ ct\\ images\\ reveal\\ a\\ large\\ enhancing\\ mass\\ involving\\ the\\ upper\\ pole\\ of\\ the\\ right\\ kidney\\.\\ \\ the\\ mass\\ has\\ multiple\\ foci\\ of\\ fat\\ density\\.\ \(0\)\
\-\ catheter\\ angiogram\\ demonstrates\\ a\\ single\\ right\\ renal\\ artery\\,\\ with\\ a\\ defect\\ in\\ the\\ upper\\ pole\\ corresponding\\ to\\ the\\ angiomyolipoma\\.\\ \\ there\\ is\\ minimal\\ blood\\ supply\\ to\\ this\\ lesion\\ although\\ it\\ arises\\ from\\ a\\&\\#8232\\;\\ single\\ upper\\ pole\\ branch\\.\\ the\\ artery\\ supplying\\ this\\ mass\\ was\\ subselected\\ with\\ a\\ microcatheter\\ and\\ \\&\\#8232\\;then\\ embolized\\ to\\ obtain\\ arterial\\ stasis\\ using\\ 300\\ to\\ 500\\ micron\\&\\#8232\\;\\ bead\\ block\\.\\ \\ \ \(0\)\
\-\ post\\-embolization\\ image\\ shows\\ absent\\ flow\\ to\\ the\\ mass\\.\ \(0\)\
\-\ renal\\ angiomyolipoma\ \(9\)\
\-\ \\â\\€\\¢\\ angiomyolipoma\ \(2\)\
\-\ \\â\\€\\¢\\ renal\\ cell\\ carcinoma\ \(1\)\
\-\ 76\\ y\\.o\\.\\ woman\\ with\\ right\\ flank\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 8232\\:\\ 0\\.09775294819535009\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.0903852066287167\ \(0\)\
\-\ embolization\\:\\ 0\\.05235837522388184\ \(0\)\
\-\ pole\\:\\ 0\\.05235837522388184\ \(0\)\
\-\ renal\\:\\ 0\\.045043430692246825\ \(0\)\
\-\ \\#\\:\\ 0\\.04410113972290642\ \(0\)\
\-\ \\&\\:\\ 0\\.03949194594922936\ \(0\)\
\-\ 16\\:45\\-50\\.\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ micron\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ catheter\\:\\ 0\\.036017440549597934\ \(0\)\
\-\ kothary\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ soulen\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ clark\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ interv\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ bead\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ \\;\\:\\ 0\\.03553370506057182\ \(0\)\
\-\ vasc\\:\\ 0\\.033846079540782406\ \(0\)\
\-\ subselected\\:\\ 0\\.033846079540782406\ \(0\)\
\-\ arterial\\:\\ 0\\.03281004042747957\ \(0\)\
\-\ tw\\:\\ 0\\.0325843160651167\ \(0\)\
\-\ hemorrage\\:\\ 0\\.03160561627865087\ \(0\)\
\-\ amls\\:\\ 0\\.03160561627865087\ \(0\)\
\-\ microcatheter\\:\\ 0\\.03160561627865087\ \(0\)\
\-\ post\\-embolization\\:\\ 0\\.030805960327800187\ \(0\)\
\-\ single\\:\\ 0\\.030382985004302032\ \(0\)\
\-\ 500\\:\\ 0\\.02856549706566865\ \(0\)\
\-\ 5\\.3\\:\\ 0\\.028147469961263716\ \(0\)\
\-\ technical\\:\\ 0\\.0274147766074779\ \(0\)\
\-\ supplying\\:\\ 0\\.0274147766074779\ \(0\)\
\-\ upper\\:\\ 0\\.027132638228535767\ \(0\)\
\-\ 300\\:\\ 0\\.027089741641891398\ \(0\)\
\-\ radiol\\:\\ 0\\.026504077639152263\ \(0\)\
\-\ mass\\:\\ 0\\.026062741380429046\ \(0\)\
\-\ 4\\.2\\:\\ 0\\.025750348442105515\ \(0\)\
\-\ selective\\:\\ 0\\.025750348442105515\ \(0\)\
\-\ 4\\.1\\:\\ 0\\.025525377852686434\ \(0\)\
\-\ 4\\.5\\:\\ 0\\.02531138590457489\ \(0\)\
\-\ stasis\\:\\ 0\\.02531138590457489\ \(0\)\
\-\ embolized\\:\\ 0\\.02491238687735679\ \(0\)\
\-\ x\\:\\ 0\\.024728652064451552\ \(0\)\
\-\ sporadic\\:\\ 0\\.02420912964018495\ \(0\)\
\-\ block\\:\\ 0\\.02420912964018495\ \(0\)\
\-\ obtain\\:\\ 0\\.02374702211536992\ \(0\)\
\-\ success\\:\\ 0\\.02282719522509769\ \(0\)\
\-\ arises\\:\\ 0\\.022485258639704218\ \(0\)\
\-\ artery\\:\\ 0\\.022320438527264903\ \(0\)\
\-\ mc\\:\\ 0\\.021968666378053413\ \(0\)\
\-\ n\\:\\ 0\\.02177794220287912\ \(0\)\
\-\ effective\\:\\ 0\\.021334538181513464\ \(0\)\
\-\ 76\\:\\ 0\\.021169010427202734\ \(0\)\
\-\ supply\\:\\ 0\\.020855593918509118\ \(0\)\
\-\ long\\-term\\:\\ 0\\.02070690290238771\ \(0\)\
\-\ branch\\:\\ 0\\.02028887579798277\ \(0\)\
\-\ 2005\\:\\ 0\\.02022292019550672\ \(0\)\
\-\ cm\\:\\ 0\\.020104878226464788\ \(0\)\
\-\ minimally\\:\\ 0\\.01950030952412051\ \(0\)\
\-\ corresponding\\:\\ 0\\.019077238181192606\ \(0\)\
\-\ 100\\:\\ 0\\.018928547165071197\ \(0\)\
\-\ invasive\\:\\ 0\\.018832148451392357\ \(0\)\
\-\ interval\\:\\ 0\\.018379586011764152\ \(0\)\
\-\ angiogram\\:\\ 0\\.018128891214220517\ \(0\)\
\-\ flank\\:\\ 0\\.0176303854314463\ \(0\)\
\-\ incidence\\:\\ 0\\.0171828009825245\ \(0\)\
\-\ j\\:\\ 0\\.01692847090511069\ \(0\)\
\-\ reveal\\:\\ 0\\.01668808390293966\ \(0\)\
\-\ recurrence\\:\\ 0\\.01635053547690401\ \(0\)\
\-\ using\\:\\ 0\\.016270056798534726\ \(0\)\
\-\ absent\\:\\ 0\\.016243555419341908\ \(0\)\
\-\ indicated\\:\\ 0\\.016217213208551504\ \(0\)\
\-\ near\\:\\ 0\\.016217213208551504\ \(0\)\
\-\ foci\\:\\ 0\\.016087824329618618\ \(0\)\
\-\ enhanced\\:\\ 0\\.01603711896821039\ \(0\)\
\-\ al\\:\\ 0\\.01588842795208898\ \(0\)\
\-\ increase\\:\\ 0\\.01572109564522768\ \(0\)\
\-\ et\\:\\ 0\\.015339466798781938\ \(0\)\
\-\ treatment\\:\\ 0\\.015172078592990235\ \(0\)\
\-\ results\\:\\ 0\\.015129571969055467\ \(0\)\
\-\ minimal\\:\\ 0\\.014756491098249112\ \(0\)\
\-\ rate\\:\\ 0\\.014608427589806329\ \(0\)\
\-\ rare\\:\\ 0\\.014554167538040771\ \(0\)\
\-\ based\\:\\ 0\\.014292501588890177\ \(0\)\
\-\ defect\\:\\ 0\\.014029593536403186\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.013745739926279718\ \(0\)\
\-\ risk\\:\\ 0\\.01357546775157494\ \(0\)\
\-\ then\\:\\ 0\\.01333757402816706\ \(0\)\
\-\ kidney\\:\\ 0\\.01320343620635969\ \(0\)\
\-\ involving\\:\\ 0\\.013150909052646024\ \(0\)\
\-\ to\\:\\ 0\\.013111740171495192\ \(0\)\
\-\ underwent\\:\\ 0\\.01286050892753605\ \(0\)\
\-\ although\\:\\ 0\\.012657584563932471\ \(0\)\
\-\ size\\:\\ 0\\.012565245049906892\ \(0\)\
\-\ flow\\:\\ 0\\.012386201214291737\ \(0\)\
\-\ density\\:\\ 0\\.01233171647745596\ \(0\)\
\-\ right\\:\\ 0\\.011863575119873904\ \(0\)\
\-\ enhancing\\:\\ 0\\.01175418216177526\ \(0\)\
\-\ image\\:\\ 0\\.011706970027621055\ \(0\)\
\-\ fat\\:\\ 0\\.011398738258252777\ \(0\)\
\-\ from\\:\\ 0\\.011109085203107124\ \(0\)\
\-\ y\\.o\\:\\ 0\\.010817453651696052\ \(0\)\
\-\ axial\\:\\ 0\\.010696453842402944\ \(0\)\
\-\ \\,\\:\\ 0\\.010685923638840291\ \(0\)\
\-\ carcinoma\\:\\ 0\\.010622489780771344\ \(0\)\
\-\ a\\:\\ 0\\.010436836889963191\ \(0\)\
\-\ an\\:\\ 0\\.010365481265655525\ \(0\)\
\-\ shows\\:\\ 0\\.010304270612845959\ \(0\)\
\-\ blood\\:\\ 0\\.010229873125040787\ \(0\)\
\-\ cell\\:\\ 0\\.010123862770094237\ \(0\)\
\-\ due\\:\\ 0\\.010001215583126489\ \(0\)\
\-\ increased\\:\\ 0\\.009168792902630068\ \(0\)\
\-\ \\%\\:\\ 0\\.008742636111166699\ \(0\)\
\-\ was\\:\\ 0\\.008669101072049884\ \(0\)\
\-\ woman\\:\\ 0\\.008657469067933798\ \(0\)\
\-\ this\\:\\ 0\\.008431028186966078\ \(0\)\
\-\ it\\:\\ 0\\.00842477361637288\ \(0\)\
\-\ contrast\\:\\ 0\\.008389367047403094\ \(0\)\
\-\ large\\:\\ 0\\.00819536154311877\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008186935094970114\ \(0\)\
\-\ multiple\\:\\ 0\\.007893885980172231\ \(0\)\
\-\ after\\:\\ 0\\.007754391239514045\ \(0\)\
\-\ lesion\\:\\ 0\\.007634014149124801\ \(0\)\
\-\ is\\:\\ 0\\.007398562873483232\ \(0\)\
\-\ images\\:\\ 0\\.00718975391205857\ \(0\)\
\-\ has\\:\\ 0\\.00703815776532578\ \(0\)\
\-\ the\\:\\ 0\\.006669921630438086\ \(0\)\
\-\ as\\:\\ 0\\.005669199587254946\ \(0\)\
\-\ there\\:\\ 0\\.0055776998090569675\ \(0\)\
\-\ in\\:\\ 0\\.005544700396582301\ \(0\)\
\-\ ct\\:\\ 0\\.0052425598832984335\ \(0\)\
\-\ \\:\\:\\ 0\\.004957345684169583\ \(0\)\
\-\ pain\\:\\ 0\\.004577228804959362\ \(0\)\
\-\ patient\\:\\ 0\\.0037569821531420523\ \(0\)\
\-\ of\\:\\ 0\\.0025549079122365883\ \(0\)\
\-\ \\.\\:\\ 0\\.0021797960761528413\ \(0\)\
\-\ with\\:\\ 0\\.0020527048436822758\ \(0\)\
\-\ and\\:\\ 0\\.0015790263660720916\ \(0\)\
